|
1
|
Gladson CL, Prayson RA and Liu WM: The
pathobiology of glioma tumors. Annu Rev Pathol. 5:33–50. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 15
Suppl 2:ii1–ii56. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morgan LL: The epidemiology of glioma in
adults: A ‘state of the science’ review. Neuro Oncol. 17:623–624.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hervey-Jumper SL and Berger MS: Maximizing
safe resection of low- and high-grade glioma. J Neuro Oncol.
130:pp269–282. 2016. View Article : Google Scholar
|
|
6
|
Stavrovskaya AA, Shushanov SS and
Rybalkina EY: Problems of glioblastoma multiforme drug resistance.
Biochemistry (Mosc). 81:91–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang C, Li C, Li J, Han J, Shang D, Zhang
Y, Zhang W, Yao Q, Han L, Xu Y, et al: Identification of
miRNA-mediated core gene module for glioma patient prediction by
integrating high-throughput miRNA, mRNA expression and pathway
structure. PLoS One. 9:e969082014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adlakha YK and Saini N: Brain microRNAs
and insights into biological functions and therapeutic potential of
brain enriched miRNA-128. Mol Cancer. 13:332014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Onishi M, Ichikawa T, Kurozumi K and Date
I: Angiogenesis and invasion in glioma. Brain Tumor Patho.
28:pp13–24. 2011. View Article : Google Scholar
|
|
10
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Downregulation of Pdcd4 by mir-21 facilitates glioblastoma
proliferation in vivo. Neuro Oncol. 13:580–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Zhao S, Zhen Y, Li Q, Teng L, Asai A
and Kawamoto K: A miR-21 inhibitor enhances apoptosis and reduces
G(2)-M accumulation induced by ionizing radiation in human
glioblastoma U251 cells. Brain Tumor Pathol. 28:209–214. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Zhang J, Hao J, Shi Z, Wang Y,
Han L, Yu S, You Y, Jiang T, Wang J, et al: High level of
miR-221/222 confers increased cell invasion and poor prognosis in
glioma. J Transl Med. 10:e1192012. View Article : Google Scholar
|
|
13
|
Ernst A, Campos B, Meier J, Devens F,
Liesenberg F, Wolter M, Reifenberger G, Herold-Mende C, Lichter P
and Radlwimmer B: De-repression of CTGF via the miR-17-92 cluster
upon differentiation of human glioblastoma spheroid cultures.
Oncogene. 29:3411–3422. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Costa PM, Cardoso AL, Mano M and de Lima
MC: MicroRNAs in glioblastoma: Role in pathogenesis and
opportunities for targeted therapies. CNS Neurol Disord Drug
Targets. 14:222–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu DG, Wang YY, Fan LG, Luo H, Han B, Sun
LH, Wang XF, Zhang JX, Cao L, Wang XR, et al: MicroRNA-7 regulates
glioblastoma cell invasion via targeting focal adhesion kinase
expression. Chin Med J (Engl). 124:2616–2621. 2011.PubMed/NCBI
|
|
16
|
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P
and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG
cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003.
2010.PubMed/NCBI
|
|
17
|
Gabriely G, Wurdinger T, Kesari S, Esau
CC, Burchard J, Linsley PS and Krichevsky AM: MicroRNA 21 promotes
glioma invasion by targeting matrix metalloproteinase regulators.
Mol Cell Biol. 28:5369–5380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu J, Li CX, Li YS, Lv JY, Ma Y, Shao TT,
Xu LD, Wang YY, Du L, Zhang YP, et al: MiRNA-miRNA synergistic
network: Construction via co-regulating functional modules and
disease miRNA topological features. Nucleic Acids Res. 39:825–836.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu S, Huang M, Nguyen PK, Gong Y, Li Z,
Jia F, Lan F, Liu J, Nag D, Robbins RC and Wu JC: Novel microRNA
prosurvival cocktail for improving engraftment and function of
cardiac progenitor cell transplantation. Circulation. 124 11
Suppl:S27–S34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu W, Zhao Y, Xu Y, Sun Y, Wang Z, Yuan W
and Du Z: Dissection of protein interactomics highlights microRNA
synergy. PLoS One. 8:e633422013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh S, Narang AS and Mahato RI:
Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.
Pharm Res. 28:2996–3015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Dutta A and Abounader R: The role
of microRNAs in glioma initiation and progression. Front Biosci
(Landmark Ed). 17:700–712. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Codo P, Weller M, Meister G, Szabo E,
Steinle A, Wolter M, Reifenberger G and Roth P: MicroRNA mediated
down-regulation of NKG2D ligands contributes to glioma immune
escape. Oncotarget. 5:7651–7662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Visani M, de Biase D, Marucci G, Cerasoli
S, Nigrisoli E, Reggiani ML Bacchi, Albani F, Baruzzi A and Pession
A; PERNO study group, : Expression of 19 microRNAs in glioblastoma
and comparison with other brain neoplasia of grades I–III. Mol
Oncol. 8:417–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng SY, Dong CG, Wu K, Wang XG, Qiao J
and Shao JF: Lentiviral expression of anti-microRNAs targeting
miR-27a inhibits proliferation and invasiveness of U87 glioma
cells. Mol Med Rep. 6:275–281. 2012.PubMed/NCBI
|
|
27
|
Shi R, Wang PY, Li XY, Chen JX, Li Y,
Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W and Cheng SJ: Exosomal
levels of miRNA-21 from cerebrospinal fluids associated with poor
prognosis and tumor recurrence of glioma patients. Oncotarget.
6:26971–26981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gwak HS, Kim TH, Jo GH, Kim YJ, Kwak HJ,
Kim JH, Yin J, Yoo H, Lee SH and Park JB: Silencing of microRNA-21
confers radio-sensitivity through inhibition of the PI3K/AKT
pathway and enhancing autophagy in malignant glioma cell lines.
PLoS One. 7:e474492012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han L, Yue X, Zhou X, Lan FM, You G, Zhang
W, Zhang KL, Zhang CZ, Cheng JQ, Yu SZ, et al: MicroRNA-21
expression is regulated by β-catenin/STAT3 pathway and promotes
glioma cell invasion by direct targeting RECK. CNS Neurosci Ther.
18:573–583. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yao X, Li W, Wang Y, Ding Z, Hou W, Zeng
M, Deng G, Zhang J and Yang H: Expression of hsa-miR-20a in human
glioma tissues and its effect on the proliferation of human glioma
cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 32:198–201. 2012.(In
Chinese). PubMed/NCBI
|
|
31
|
Kasinski AL, Kelnar K, Stahlhut C,
Orellana E, Zhao J, Shimer E, Dysart S, Chen X, Bader AG and Slack
FJ: A combinatorial microRNA therapeutics approach to suppressing
non-small cell lung cancer. Oncogene. 34:3547–3555. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stahlhut C and Slack FJ: Combinatorial
action of MicroRNAs let-7 and miR-34 Effectively synergizes with
erlotinib to suppress non-small cell lung cancer cell
proliferation. Cell Cycle. 14:2171–2180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Devulapally R, Sekar NM, Sekar TV, Foygel
K, Massoud TF, Willmann JK and Paulmurugan R: Polymer nanoparticles
mediated codelivery of antimiR-10b and antimiR-21 for achieving
triple negative breast cancer therapy. ACS Nano. 9:2290–2302. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jin H, Yu Y, Chrisler WB, Xiong Y, Hu D
and Lei C: Delivery of MicroRNA-10b with polylysine nanoparticles
for inhibition of breast cancer cell wound healing. Breast Cancer
(Auckl). 6:9–19. 2012.PubMed/NCBI
|
|
35
|
Fernandez-Fernandez A, Manchanda R and
McGoron AJ: Theranostic applications of nanomaterials in cancer:
Drug delivery, image-guided therapy, and multifunctional platforms.
Appl Biochem Biotechnol. 165:1628–1651. 2011. View Article : Google Scholar : PubMed/NCBI
|
